| 2026-08-07 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-07-31 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-07-30 | Press release | CareDx Announces Second Quarter 2026 Financial Results |
| 2026-07-30 | Presentation | Presentation |
| 2026-07-30 | Press release | CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 |
| 2026-07-16 | Press release | CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 |
| 2026-07-16 | Press release | CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination |
| 2026-07-01 | Press release | CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology |
| 2026-06-30 | Press release | CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific |
| 2026-06-18 | Press release | CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Trans |
| 2026-06-16 | Press release | CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology |
| 2026-05-20 | Press release | CareDx to Participate in Upcoming Investor Conferences |
| 2026-05-11 | Press release | CareDx Announces Dismissal of 2021 Qui Tam Suit |
| 2026-05-01 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-04-28 | Press release | Press Release of Q1 2026, aspx file, (opens in new window) |
| 2026-04-28 | Press release | CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing |
| 2026-04-28 | Earnings deck | Presentation
of Q1 2026, PDF file, (opens in new window) |
| 2026-04-28 | Press release | Download
(opens in new window) |
| 2026-04-24 | ESG report | ESG Report of 2025, PDF file, (opens in new window) |
| 2026-04-23 | Press release | CareDx Announces Dismissal of 2021 Qui Tam Suit |
| 2026-04-21 | Press release | CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for |
| 2026-04-20 | Press release | CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing |
| 2026-04-15 | Press release | CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Qu |
| 2026-04-14 | Press release | CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 |
| 2026-02-27 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-02-24 | Press release | Press Release |
| 2026-02-24 | Press release | CareDx Announces Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-24 | Press release | CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer |
| 2026-02-24 | Earnings deck | CareDx 2025 Q4 and Full Year Financial Results Conference Call |
| 2026-02-18 | Press release | CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference |
| 2026-02-12 | Press release | CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and M |
| 2026-02-12 | Presentation | AlloHeme™ Clinical Validation Data Review and Launch Timeline |
| 2026-02-10 | Press release | CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 |
| 2026-02-03 | Press release | CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meet |
| 2026-01-27 | Press release | CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2026-01-12 | Press release | CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results |
| 2025-12-26 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2025-11-07 | Press release | CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2025-11-06 | Press release | CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 |
| 2025-11-04 | Presentation | Presentation |